← Back to Search

iTEAR100 Device for Dry Eye Syndrome

Phase 1
Recruiting
Research Sponsored by Olympic Ophthalmics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must use iTEAR and NuLids at time of enrollment
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
No Placebo-Only Group

Summary

This trial is being done to test how well the iTEAR100 generation 2 device works when used with its new iLIDS100 disposable cover.

Who is the study for?
This clinical trial is for individuals who are experiencing Dry Eye Syndrome or Blepharitis. The study aims to assess the usability of a new device and its disposable cover, but specific eligibility criteria have not been provided.
What is being tested?
The trial is testing the iTEAR100 generation 2 device with an added component called iLIDS100. This combination is designed for eyelid cleaning (microblepharoexfoliation) and nerve stimulation to potentially help with eye conditions.
What are the potential side effects?
Since this is a usability study, side effects may include discomfort at the site of application or irritation related to the use of the device on eyelids. However, detailed potential side effects are not specified.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently using iTEAR and NuLids.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Questionnaire

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Therapeutic iLIDS armExperimental Treatment1 Intervention
Subjects apply iTEAR100 device with iLIDS100 accessory

Find a Location

Who is running the clinical trial?

Olympic Ophthalmics, Inc.Lead Sponsor
3 Previous Clinical Trials
165 Total Patients Enrolled
~113 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top